FDA approves new suppliers for scarce cancer drugs
– Katherine Hobson, The Wall Street Journal Health Blog
February 22, 2012
New supplies of two currently hard-to-find cancer drugs are on the way, according to the FDA.
As Dow Jones Newswires reports, the FDA said it would allow the temporary importation of Lipodox, made by Sun Pharma Global FZE and distributed by Caraco Pharmaceutical Laboratories, as a substitute for Johnson & Johnson’s Doxil. The drugs have the same active ingredient.
New iPhone App
Your Caregiver In Your Pocket!
Build lists of practical questions used to guide conversations between you and your doctors and nurses.
News and Updates
NCCS Policy Priorities
NCCS advocates for high-quality, coordinated health care for people with all types of cancer through:
- Quality, Comprehensive Cancer Care
- Accessible, Affordable, Comprehensive coverage
- Access to Safe and Effective Therapies for Cancer
- Clinical Trial Access and Enrollment
- Cancer Research
Connect with us:
Facebook Twitter YouTube RSSCopyright © 1995-2012 by the National Coalition for Cancer Survivorship
1010 Wayne Avenue, Suite 770 · Silver Spring, MD 20910 · 877-NCCS-YES · info@canceradvocacy.org